Dr. Gabrielle Eugenie Duprat, MD

Dr. Duprat practices at Dartmouth Hitchcock Medical Center in Lebanon, New Hampshire, part of Dartmouth-Hitchcock Health.

Dr. Duprat's NPI, 1659834760, was assigned on April 8, 2019. Dr. Duprat holds New Hampshire license 24152.

Dr. Duprat's primary practice is Dartmouth Hitchcock Medical Center, at 1 Medical Center Drive, Lebanon, NH 03756 in Grafton County. The practice phone is (603) 650-5000.

Dr. Duprat's primary practice is Dartmouth Hitchcock Medical Center in Lebanon, New Hampshire, part of Dartmouth-Hitchcock Health. Dr. Duprat is also affiliated with New London Hospital. The medical group on file is Dartmouth Hitchcock Medical Center. Dmand AI also links Dr. Duprat to 2 more group practices and clinics and 2 medical groups, each named with a free account. Dr. Duprat's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Duprat practices, 4 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Duprat's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Duprat is licensed in New Hampshire.

CMS data shows 2,735 Medicare services from Dr. Duprat across 16 procedure codes in 2024, for 690 Medicare patients. Medicare paid $75,656 for them. Every service was in an office.

CMS counts 690 Medicare patients who saw Dr. Duprat in 2024. The largest group is 65 to 74, with 338 patients. 57% of them have high blood pressure, and 55% have high cholesterol. 6% are also on Medicaid. Their average risk score is 0.89, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Duprat's median patient age at 59, with 66% women.

In 2024, Dr. Duprat wrote 739 Medicare Part D claims for 290 patients. 91% of them were for generic drugs. CMS names the drug for 604 of them, across 15 drugs with 11 or more claims each, at $252,888 in total drug cost. In 2023, CMS named 474 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Duprat for performance year 2024, reported through an alternative payment model (APM). Dr. Duprat accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Duprat as offering telehealth. CMS counts 1,007 procedures of removal of skin lesions by Dr. Duprat, more than 93% of the clinicians it reports for that procedure.

Dmand AI links 6 papers to Dr. Duprat, published from 2021 to 2024. Dr. Duprat has published most often in JAAD Case Rep. Dr. Duprat's most frequent co-authors are Michael Shane Chapman, MD, Alicia True Dagrosa, MD and Julianne Anderson Mann, MD.

CMS Open Payments shows 1 general payment to Dr. Duprat from 1 drug or device company in 2023. Food and beverage make up the largest share, 100% of the total. Pfizer Inc. paid the most, $58.